Clinical and neurocognitive profiles of a combined clinical high risk for psychosis and clinical control sample: latent class analysis

被引:0
|
作者
Stuble, Miriam [1 ,2 ]
Schultze-Lutter, Frauke [1 ,3 ,4 ]
Kaess, Michael [1 ,5 ]
Franscini, Maurizia [6 ]
Traber-Walker, Nina [6 ]
Walger, Petra [7 ]
Schimmelmann, Benno G. [1 ]
Vogeley, Kai [8 ,9 ,10 ]
Kambeitz, Joseph [8 ,9 ]
Kindler, Jochen [1 ]
Michel, Chantal [1 ]
机构
[1] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychother, Bern, Switzerland
[2] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland
[3] Heinrich Heine Univ, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[4] Airlangga Univ, Fac Psychol, Dept Psychol, Surabaya, Indonesia
[5] Heidelberg Univ, Ctr Psychosocial Med, Dept Child & Adolescent Psychiat, Heidelberg, Germany
[6] Univ Zurich, Dept Child & Adolescent Psychiat & Psychotherapy, Zurich, Switzerland
[7] Heinrich Heine Univ, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[8] Univ Cologne, Fac Med, Dept Psychiat & Psychotherapy, Cologne, Germany
[9] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[10] Inst Neurosci & Med, Res Ctr Julich, Cognit Neurosci INM3, Julich, Germany
来源
BJPSYCH OPEN | 2024年 / 10卷 / 06期
基金
瑞士国家科学基金会;
关键词
Psychotic symptoms; basic symptoms; neurocognition; clinical heterogeneity; early intervention; DSM-IV; GENERAL-POPULATION; BASIC SYMPTOMS; YOUNG-ADULTS; INTERVENTION; PREVALENCE; HETEROGENEITY; RELIABILITY; PREDICTION; STATE;
D O I
10.1192/bjo.2024.815
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background The clinical high-risk (CHR) state for psychosis demonstrates considerable clinical heterogeneity, presenting challenges for clinicians and researchers alike. Basic symptoms, to date, have largely been ignored in explorations of clinical profiles.Aims We examined clinical profiles by using a broader spectrum of CHR symptoms, including not only (attenuated) psychotic, but also basic symptoms.Method Patients (N = 875) of specialised early intervention centres for psychosis in Germany and Switzerland were assessed with the Schizophrenia Proneness Instruments and the Structured Interview for Psychosis-Risk Syndromes. Latent class analysis was applied to CHR symptoms to identify clinical profiles. Additionally, demographics, other symptoms, current non-psychotic DSM-IV axis I disorders and neurocognitive variables were assessed to further describe and compare the profiles.Results A three-class model was best fitting the data, whereby basic symptoms best differentiated between the profiles (eta 2 = 0.08-0.52). Class 1 had a low probability of CHR symptoms, the highest functioning and lowest other psychopathology, neurocognitive deficits and transition-to-psychosis rate. Class 2 had the highest probability of basic and (attenuated) positive symptoms (excluding hallucinations), lowest functioning, highest symptom load, most neurocognitive deficits and highest transition rate (55.1%). Class 3 was mostly characterised by attenuated hallucination, and was otherwise intermediate between the other two classes. Comorbidity rates were comparable across classes, with some class differences in diagnostic categories.Conclusions Our profiles based on basic and (attenuated) psychotic symptoms provide clinically useful entities by parsing out heterogeneity in clinical presentation. In future, they could guide class-specific intervention.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Neurocognitive deficits in clinical high-risk for psychosis
    An, S. K.
    Park, J. Y.
    Kim, K. R.
    Kim, B.
    Kang, J. I.
    Koo, H-K
    Lee, E.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A125 - A125
  • [2] Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis
    Zheng, Wei
    Zhang, Qing-E.
    Cai, Dong-Bin
    Ng, Chee H.
    Ungvari, Gabor S.
    Ning, Yu-Ping
    Xiang, Yu-Tao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 103 : 38 - 45
  • [3] Early and later remission from clinical high risk of psychosis. A latent class and predictor analysis
    Bjornestad, Jone
    Tjora, Tore
    Joa, Inge
    Johannessen, Jan Olav
    Saetren, Sjur Skjorshammer
    Hegelstad, Wenche ten Velden
    SCHIZOPHRENIA RESEARCH, 2024, 274 : 237 - 242
  • [4] Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis
    Shakeel, M. K.
    Lu, L.
    Woods, S. W.
    Perkins, D. O.
    Addington, J.
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2020, 48 (02) : 248 - 252
  • [5] Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms
    Hur, Ji-Won
    Shin, Na Young
    Jang, Joon Hwan
    Shim, Geumsook
    Park, Hye Yoon
    Hwang, Jae Yeon
    Kim, Sung Nyun
    Yoo, Jung Hyun
    Hong, Kyung Sue
    Kwon, Jun Soo
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 (02): : 161 - 169
  • [6] Three-year course of clinical high-risk symptoms for psychosis in the community: a latent class analysis
    Michel, C.
    Osman, N.
    Rinaldi, G.
    Schimmelmann, B. G.
    Kindler, J.
    Schultze-Lutter, F.
    EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2025, 34
  • [7] Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis
    Mourik, Kees
    Decrescenzo, Paula
    Brucato, Gary
    Gill, Kelly E.
    Arndt, Leigh
    Kimhy, David
    Keilp, John G.
    Girgis, Ragy R.
    EARLY INTERVENTION IN PSYCHIATRY, 2017, 11 (03) : 250 - 254
  • [8] Associations between symptom and neurocognitive dimensions in clinical high risk for psychosis
    Aase, Ingvild
    Langeveld, Johannes H.
    Joa, Inge
    Johannessen, Jan Olav
    Dalen, Ingvild
    Hegelstad, Wenche ten Velden
    SCHIZOPHRENIA RESEARCH-COGNITION, 2022, 29
  • [9] Clinical, Neurocognitive, and Genetic Characteristics of Youths at Familial High Risk for Psychosis
    Taylor, Jerome
    Asabere, Nana
    Calkins, Monica
    Moore, Tyler
    Tang, Sunny
    Xavier, Rose
    Wolf, Daniel
    Almasy, Laura
    Gur, Ruben
    Gur, Raquel
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S182 - S182
  • [10] Neurocognitive Functioning of Adolescents with Clinical High Risk for Psychosis, other Psychiatric Symptoms, and Psychosis
    Orlandi, M.
    Iorio, M.
    Rogantini, C.
    Vecchio, A.
    Coci, C.
    Casini, E.
    Borgattii, R.
    Mensi, M.
    EUROPEAN PSYCHIATRY, 2022, 65 : S322 - S322